Artelo Biosciences, Inc. (ARTL)
NASDAQ: ARTL · Real-Time Price · USD
0.948
+0.016 (1.67%)
At close: Dec 20, 2024, 4:00 PM
0.950
+0.002 (0.25%)
After-hours: Dec 20, 2024, 6:21 PM EST

Artelo Biosciences Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2021 FY 2020 2019 - 2015
Period Ending
Sep '24 Dec '23 Dec '22 Dec '21 Aug '21 Aug '20 2019 - 2015
Net Income
-9.12-9.29-10.08-12.11-7.44-4.66
Upgrade
Loss (Gain) From Sale of Investments
-0.42-0.64-0.21-0.020-
Upgrade
Stock-Based Compensation
0.841.022.462.81.530.38
Upgrade
Other Operating Activities
0.030.040.040.030.01-0.03
Upgrade
Change in Accounts Payable
-0.270.270.021.5-00.13
Upgrade
Change in Other Net Operating Assets
0.560.39-0.24-0.21-0.24-0.17
Upgrade
Operating Cash Flow
-8.38-8.21-8.01-8-6.14-4.35
Upgrade
Investment in Securities
10.013.512.96-30.1-3.44-
Upgrade
Investing Cash Flow
10.013.512.96-30.1-3.44-
Upgrade
Short-Term Debt Issued
----00.01
Upgrade
Total Debt Issued
----00.01
Upgrade
Short-Term Debt Repaid
-----0.01-0.01
Upgrade
Total Debt Repaid
----0-0.01-0.01
Upgrade
Net Debt Issued (Repaid)
----0-0.010
Upgrade
Issuance of Common Stock
0.090.57-54.7914.121.98
Upgrade
Financing Cash Flow
0.090.57-54.7814.111.98
Upgrade
Foreign Exchange Rate Adjustments
-0.06-0.22-0.08-0.050.08
Upgrade
Net Cash Flow
1.72-4.07-5.2716.64.49-2.28
Upgrade
Free Cash Flow
-8.38-8.21-8.01-8-6.14-4.35
Upgrade
Free Cash Flow Per Share
-2.61-2.77-2.83-3.59-4.93-17.59
Upgrade
Levered Free Cash Flow
-4.92-4.64-4.31--3.18-3.24
Upgrade
Unlevered Free Cash Flow
-4.92-4.64-4.3--3.18-3.24
Upgrade
Change in Net Working Capital
-0.21-0.550.33-0.060.7
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.